Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection

scientific article (publication date: 12 October 2010)

Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2010PLoSO...513251B
P356DOI10.1371/JOURNAL.PONE.0013251
P3181OpenCitations bibliographic resource ID297609
P932PMC publication ID2953496
P698PubMed publication ID20967263
P5875ResearchGate publication ID47520942

P50authorKaren L MossmanQ87062429
Martin R StampfliQ56426986
P2093author name stringEarl G Brown
Carla M T Bauer
John D Taylor
Fernando M Botelho
Caleb C J Zavitz
Kristen N Lambert
P2860cites workCigarette smoke exposure attenuates cytokine production by mouse alveolar macrophagesQ81301795
Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in miceQ84013691
Animal Models of Cigarette Smoke-Induced COPD*Q22306060
Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virusQ28589623
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperQ29614960
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.Q30375496
Toward a consensus definition for COPD exacerbationsQ33937749
Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD).Q36292150
Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbationsQ36305342
Modelling COPD in mice.Q36312380
Acetylcholine-induced calcium signaling and contraction of airway smooth muscle cells in lung slicesQ36445078
The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary diseaseQ36601766
Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in miceQ36789890
Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.Q36791049
Global burden of COPD: risk factors, prevalence, and future trendsQ36926621
COPD exacerbations: defining their cause and preventionQ36926629
Occasional review: influenza in COPD: pathogenesis, prevention, and treatmentQ37017233
Immunology of asthma and chronic obstructive pulmonary diseaseQ37084506
How cigarette smoke skews immune responses to promote infection, lung disease and cancerQ37426272
Targeting PPAR receptors in the airway for the treatment of inflammatory lung diseaseQ37447470
The 2007 GOLD Guidelines: a comprehensive care framework.Q37570645
New drugs for exacerbations of chronic obstructive pulmonary diseaseQ37589154
Pioglitazone: side effect and safety profileQ37696508
Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropiumQ37724621
Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.Q40101329
CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortalityQ44752156
Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profileQ44927752
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic ratsQ44989032
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in miceQ45006106
PPAR-gamma agonists as therapy for diseases involving airway neutrophiliaQ45006883
Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccinationQ45411250
Influenza virus host response of C57Bl/6 mice treated with TACI-IgQ45416917
Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed guinea pigs.Q46203001
Peroxisome proliferator-activated receptors as novel targets in lung diseaseQ46483180
Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infectionQ47939820
Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled studyQ47970766
Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe ExacerbationsQ58877199
Airway infection accelerates decline of lung function in chronic obstructive pulmonary diseaseQ77324413
Cigarette smoke impacts immune inflammatory responses to influenza in miceQ79195225
Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysemaQ80405269
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesImageQuantQ112270642
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectchronic obstructive pulmonary diseaseQ199804
P304page(s)e13251
P577publication date2010-10-12
P1433published inPLOS OneQ564954
P1476titleTreating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection
P478volume5

Reverse relations

cites work (P2860)
Q30355446Adjunctive therapies and immunomodulating agents for severe influenza.
Q30429289Adjunctive therapies and immunomodulatory agents in the management of severe influenza
Q94571389An Update on Current Therapeutic Drugs Treating COVID-19
Q57097245Animal models of chronic obstructive pulmonary disease
Q36579569Apocynin and ebselen reduce influenza A virus-induced lung inflammation in cigarette smoke-exposed mice
Q42251246Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke
Q34634788Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis.
Q42260374Development of a mouse model mimicking key aspects of a viral asthma exacerbation
Q34894660How to approach and treat viral infections in ICU patients
Q27311393IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice
Q38977628Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models
Q30423093Immunopathogenesis of 2009 pandemic influenza
Q59354505Impact of Cigarette Smoke Exposure on the Lung Fibroblastic Response after Influenza Pneumonia
Q35129269Impact of cigarette smoke on the human and mouse lungs: a gene-expression comparison study
Q37057787Inflammation and emphysema in cigarette smoke-exposed mice when instilled with poly (I:C) or infected with influenza A or respiratory syncytial viruses
Q37583861Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to β-adrenoceptor agonists in mouse lung
Q30358340Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice.
Q27023723Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments
Q38181583Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?
Q34470424Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2.
Q47648337Modeling tuberculosis pathogenesis through ex vivo lung tissue infection.
Q41196865Mouse lung slices: An ex vivo model for the evaluation of antiviral and anti-inflammatory agents against influenza viruses
Q35903449NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease
Q38131512New anti-inflammatory targets for chronic obstructive pulmonary disease.
Q38756064Novel approaches to the management of noneosinophilic asthma
Q92494978Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection
Q28660263Persistence of pulmonary tertiary lymphoid tissues and anti-nuclear antibodies following cessation of cigarette smoke exposure
Q91782536Ponatinib Protects Mice From Lethal Influenza Infection by Suppressing Cytokine Storm
Q37426720Recent advances in pre-clinical mouse models of COPD.
Q41682794Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway
Q27317947Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice
Q35104537Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist
Q47132665Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice
Q35185316Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation
Q38694783The activation of NLRP3-inflammsome by stimulation of diesel exhaust particles in lung tissues from emphysema model and RAW 264.7 cell line
Q30426929The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat
Q38201056The influence of virus infections on the course of COPD.
Q47554935The role of adjuvant immunomodulatory agents for treatment of severe influenza
Q28535004Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation
Q38261287Translational models of lung disease
Q92030137Use of precision cut lung slices as a translational model for the study of lung biology